365 related articles for article (PubMed ID: 12016468)
1. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.
Hay ID; Thompson GB; Grant CS; Bergstralh EJ; Dvorak CE; Gorman CA; Maurer MS; McIver B; Mullan BP; Oberg AL; Powell CC; van Heerden JA; Goellner JR
World J Surg; 2002 Aug; 26(8):879-85. PubMed ID: 12016468
[TBL] [Abstract][Full Text] [Related]
2. Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).
Hay ID; Johnson TR; Kaggal S; Reinalda MS; Iniguez-Ariza NM; Grant CS; Pittock ST; Thompson GB
World J Surg; 2018 Feb; 42(2):329-342. PubMed ID: 29030676
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
4. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.
Hay ID; McConahey WM; Goellner JR
Trans Am Clin Climatol Assoc; 2002; 113():241-60. PubMed ID: 12053713
[TBL] [Abstract][Full Text] [Related]
5. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
7. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
8. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
9. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.
Hay ID
J Surg Oncol; 2006 Dec; 94(8):692-700. PubMed ID: 17131429
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
13. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
14. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
15. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period.
Hay ID; Grant CS; van Heerden JA; Goellner JR; Ebersold JR; Bergstralh EJ
Surgery; 1992 Dec; 112(6):1139-46; discussion 1146-7. PubMed ID: 1455316
[TBL] [Abstract][Full Text] [Related]
17. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome in patients with papillary thyroid carcinoma.
Kjellman P; Zedenius J; Lundell G; Bäckdahl M; Farnebo LO; Hamberger B; Larsson C; Wallin G
Eur J Surg Oncol; 2006 Apr; 32(3):345-52. PubMed ID: 16459050
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.
Lo CY; Chan WF; Lam KY; Wan KY
World J Surg; 2004 Nov; 28(11):1103-9. PubMed ID: 15490070
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
